Quent Capital LLC Has $313,000 Stock Holdings in HCA Healthcare, Inc. $HCA

Quent Capital LLC lifted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 18.4% in the second quarter, HoldingsChannel reports. The institutional investor owned 817 shares of the company’s stock after buying an additional 127 shares during the period. Quent Capital LLC’s holdings in HCA Healthcare were worth $313,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of HCA. Nuveen LLC acquired a new stake in HCA Healthcare in the 1st quarter valued at about $569,217,000. Pacer Advisors Inc. lifted its stake in HCA Healthcare by 6,237.9% in the 1st quarter. Pacer Advisors Inc. now owns 1,350,933 shares of the company’s stock valued at $466,815,000 after purchasing an additional 1,329,618 shares during the last quarter. Price T Rowe Associates Inc. MD raised its holdings in HCA Healthcare by 83.4% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company’s stock valued at $829,104,000 after acquiring an additional 1,091,416 shares during the period. Goldman Sachs Group Inc. raised its holdings in HCA Healthcare by 49.1% in the 1st quarter. Goldman Sachs Group Inc. now owns 1,781,459 shares of the company’s stock valued at $615,583,000 after acquiring an additional 587,036 shares during the period. Finally, Abdiel Capital Advisors LP bought a new position in HCA Healthcare in the 1st quarter valued at about $164,835,000. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research analysts have recently commented on HCA shares. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $444.00 target price on shares of HCA Healthcare in a report on Tuesday, August 26th. Robert W. Baird raised their target price on shares of HCA Healthcare from $380.00 to $423.00 and gave the stock a “neutral” rating in a report on Thursday, August 14th. Truist Financial raised their target price on shares of HCA Healthcare from $390.00 to $415.00 and gave the stock a “buy” rating in a report on Wednesday, July 16th. Royal Bank Of Canada lowered their target price on shares of HCA Healthcare from $404.00 to $401.00 and set an “outperform” rating on the stock in a report on Monday, July 28th. Finally, Wells Fargo & Company lowered their target price on shares of HCA Healthcare from $385.00 to $375.00 and set an “equal weight” rating on the stock in a report on Thursday, August 14th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and nine have assigned a Hold rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $407.75.

HCA Healthcare Price Performance

Shares of NYSE:HCA opened at $429.52 on Friday. The company’s 50 day simple moving average is $397.53 and its 200 day simple moving average is $372.65. The stock has a market capitalization of $100.50 billion, a price-to-earnings ratio of 18.05, a price-to-earnings-growth ratio of 1.35 and a beta of 1.40. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $432.36.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, beating analysts’ consensus estimates of $6.20 by $0.64. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The firm had revenue of $18.61 billion for the quarter, compared to analyst estimates of $18.49 billion. During the same quarter last year, the business posted $5.50 earnings per share. The company’s quarterly revenue was up 6.4% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th were given a $0.72 dividend. The ex-dividend date was Tuesday, September 16th. This represents a $2.88 dividend on an annualized basis and a yield of 0.7%. HCA Healthcare’s dividend payout ratio (DPR) is currently 12.11%.

Insiders Place Their Bets

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the firm’s stock in a transaction that occurred on Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the sale, the executive vice president owned 31,503 shares in the company, valued at $13,194,716.52. This trade represents a 10.85% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. 1.30% of the stock is owned by corporate insiders.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.